Canaccord Genuity Maintains Buy on Twist Bioscience, Lowers Price Target to $150

Benzinga · 21h ago
Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $205 to $150.